Mark Shearman's Location
Boston, MA, US
Mark Shearman's Work
- Chief Executive Officer @ APRINOIA Therapeutics
- Advisory Board Chair @ APRINOIA Therapeutics
- Founder @ Sharp Focus Consulting LLC
- Chief Scientific Officer and Executive Vice-President @ Editas Medicine
- Chief Scientific Officer @ AGTC
- Senior Vice-President, Global Research and Early Development; Head Neurology Therapeutic Area @ EMD Serono, Inc.
- Vice-President, Global Research and Early Development; Head, Multiple Sclerosis Research Platform. @ EMD Serono, Inc.
- Vice-President, Global Head Parkinson's disease and Alzheimer's disease research; Vice-President, Head @ EMD Serono, Inc.
- Executive Director, Boston @ Merck
- Neuroscience Site Lead, Boston @ Merck
Mark Shearman's Education
- Max Planck Institute, Dept. of Molecular Biology, Munich, Germany
Post-Doctoral Fellow, Laboratory of Professor Axel Ullrich (c-KIT Receptor Tyrosine Kinase signal transduction)
1990 - 1992 - Kobe University School of Medicine, Dept. of Biochemistry, Kobe, Japan
Post-Doctoral Fellow, Laboratory of Professor Yasutomi Nishizuka, FRS. (Protein kinases, in particular protein kinase C)
1987 - 1990 - University of Nottingham
Ph.D. (Professor Philip Strange) (Brain monoamine receptor signalling, with a focus on Serotonin 5-HT2 receptors)
1983 - 1987
- University of Bristol
B.Sc. (Hons) (Biochemistry)
1980 - 1983
Mark Shearman's Skills
- Drug Discovery
- Neuroscience
- Pharmacology
- Alzheimer's disease
- Drug Development
- Science
- Clinical Development
- Lifesciences
- Pharmaceutical Industry
- Biotechnology
Mark Shearman's Summary
Mark Shearman, based in Boston, MA, US, is currently a Chief Executive Officer at APRINOIA Therapeutics, bringing experience from previous roles at APRINOIA Therapeutics, Sharp Focus Consulting LLC, Editas Medicine and AGTC (Applied Genetic Technologies Corporation). Mark Shearman holds a 1990 - 1992 Post-Doctoral Fellow, Laboratory of Professor Axel Ullrich in c-KIT Receptor Tyrosine Kinase signal transduction @ Max Planck Institute, Dept. of Molecular Biology, Munich, Germany. With a robust skill set that includes Drug Discovery, Neuroscience, Pharmacology, Alzheimer's disease, Drug Development and more, Mark Shearman contributes valuable insights to the industry. Mark Shearman has 2 emails on RocketReach.
5 free lookups per month.
No credit card required.
If you need more lookups,
subscriptions start at $48 USD/month.
Not the Mark Shearman you were looking for?
Find contact details for 700 million professionals.
Others Named Mark Shearman
-
45
-
1
People Like Mark Shearman
-
23
-
33
-
55+
-
23
-
View
Sharyl Fyffe-Maricich
Vice President of Molecular and Cellular Biology, Research at Ultragenyx
California, United States23 -
21
-
32
-
ViewNelson Chau
VP, Genomic Medicine at Alexion AstraZeneca Rare Disease
Cambridge, Massachusetts, United States44 -
55+
-
ViewLaura Sepp-Lorenzino
Chief Scientific Officer at Intellia Therapeutics, Inc.
Boston, Massachusetts, United States22 -
View
Mary Mallaney
Independent Consultant at Medius Consulting, LLC
Seattle, Washington, United States42 -
35+
-
55
Top APRINOIA Therapeutics Employees
-
ViewSanjay Sehgal
Senior Vice President and Global Head, Regulatory Affairs at APRINOIA Therapeutics
Cincinnati, Ohio, United States35+ -
55+
-
33
-
32
-
22
-
5+4
-
12
-
32
-
5+5
-
1
-
23
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups / month.
Search
Search over 700
million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers
(business & personal).
G2Crowd Trusted
300K+
Plugin Users
